Zacks: Brokerages Anticipate HCP, Inc. (HCP) to Post $0.46 EPS

Equities analysts expect HCP, Inc. (NYSE:HCP) to announce earnings per share (EPS) of $0.46 for the current fiscal quarter, according to Zacks. Four analysts have made estimates for HCP’s earnings, with the lowest EPS estimate coming in at $0.45 and the highest estimate coming in at $0.48. HCP reported earnings of $0.51 per share in the same quarter last year, which would indicate a negative year-over-year growth rate of 9.8%. The firm is scheduled to issue its next earnings report before the market opens on Thursday, May 3rd.

According to Zacks, analysts expect that HCP will report full-year earnings of $1.81 per share for the current financial year, with EPS estimates ranging from $1.79 to $1.83. For the next year, analysts expect that the business will post earnings of $1.82 per share, with EPS estimates ranging from $1.77 to $1.87. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research analysts that cover HCP.

How to Become a New Pot Stock Millionaire

HCP (NYSE:HCP) last announced its quarterly earnings results on Tuesday, February 13th. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.47 by $0.01. The business had revenue of $443.30 million for the quarter, compared to analyst estimates of $448.54 million. HCP had a net margin of 22.37% and a return on equity of 6.99%. The company’s revenue was down 17.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.59 EPS.

A number of equities research analysts have issued reports on HCP shares. ValuEngine lowered shares of HCP from a “buy” rating to a “hold” rating in a report on Sunday, December 31st. Zacks Investment Research lowered shares of HCP from a “hold” rating to a “sell” rating in a report on Tuesday, January 2nd. Robert W. Baird cut their price target on shares of HCP from $29.00 to $26.00 and set a “neutral” rating on the stock in a report on Friday, January 5th. BMO Capital Markets set a $25.00 price target on shares of HCP and gave the stock a “hold” rating in a report on Monday, January 15th. Finally, Jefferies Group reissued a “hold” rating and issued a $26.00 price target on shares of HCP in a report on Tuesday, February 13th. Three investment analysts have rated the stock with a sell rating, eleven have given a hold rating and five have assigned a buy rating to the company’s stock. HCP has a consensus rating of “Hold” and an average target price of $27.50.

In related news, insider Kendall K. Young bought 14,000 shares of the company’s stock in a transaction dated Wednesday, February 14th. The stock was purchased at an average cost of $21.91 per share, with a total value of $306,740.00. Following the transaction, the insider now owns 48,544 shares in the company, valued at approximately $1,063,599.04. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.14% of the company’s stock.

Large investors have recently bought and sold shares of the company. Vestpro Financial Partners Inc. dba CPF Texas purchased a new stake in shares of HCP in the 4th quarter worth about $103,000. Fieldpoint Private Securities LLC purchased a new stake in shares of HCP in the 3rd quarter worth about $147,000. Smith Shellnut Wilson LLC ADV purchased a new stake in shares of HCP in the 3rd quarter worth about $234,000. Ellington Management Group LLC purchased a new stake in shares of HCP in the 4th quarter worth about $232,000. Finally, Cullen Frost Bankers Inc. purchased a new stake in shares of HCP in the 4th quarter worth about $244,000. 88.54% of the stock is owned by hedge funds and other institutional investors.

HCP stock traded up $0.25 during trading hours on Tuesday, reaching $22.78. The stock had a trading volume of 2,440,736 shares, compared to its average volume of 4,365,648. The firm has a market cap of $10,524.92, a PE ratio of 11.68, a price-to-earnings-growth ratio of 5.53 and a beta of 0.26. HCP has a 52 week low of $21.48 and a 52 week high of $33.67. The company has a quick ratio of 0.31, a current ratio of 0.31 and a debt-to-equity ratio of 1.23.

TRADEMARK VIOLATION NOTICE: “Zacks: Brokerages Anticipate HCP, Inc. (HCP) to Post $0.46 EPS” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.dispatchtribunal.com/2018/04/17/zacks-brokerages-anticipate-hcp-inc-hcp-to-post-0-46-eps.html.

About HCP

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Get a free copy of the Zacks research report on HCP (HCP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply